Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. 基于发病机制治疗遗传性神经发育障碍的未来之路

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. TORS Base-of-Tongue Mucosectomy in Human Papilloma Virus-Negative Carcinoma of Unknown Primary

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Penetrating Orbital Sphenoid Sinus Trauma with a Wooden Stick: A Challenging Case Report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Cyrielle Maroteau
  • Moneeza Kalhan Siddiqui
  • Abirami Veluchamy
  • Fiona Carr
  • Myra White
  • Andrew J Cassidy
  • Ekaterina V Baranova
  • Eva R Rasmussen
  • Niclas Eriksson
  • Katarzyna M Bloch
  • Nancy J Brown
  • Anette Bygum
  • Par Hallberg
  • Malgorzata Karawajczyk
  • Patrik K E Magnusson
  • Qun-Ying Yue
  • Ann-Christine Syvänen
  • Christian von Buchwald
  • Ana Alfirevic
  • Anke H Maitland-van der Zee
  • Mia Wadelius
  • Colin N A Palmer
  • PREDICTION-ADR
Vis graf over relationer

Angioedema occurring in the head and neck region is a rare and sometimes life-threatening adverse reaction to angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). Few studies have investigated the association of common variants with this extreme reaction, but none have explored the combined influence of rare variants yet. Adjudicated cases of ACEI-induced angioedema (ACEI-AE) or ARB-induced angioedema (ARB-AE) and controls were recruited at five different centers. Sequencing of 1,066 samples (408 ACEI-AE, ARB-AE, and 658 controls) was performed using exome-enriched sequence data. A common variant of the F5 gene that causes an increase in blood clotting (rs6025, p.Arg506Gln, also called factor V Leiden), was significantly associated with both ACEI-AE and ARB-AE (odds ratio: 2.85, 95% confidence interval (CI), 1.89-4.25). A burden test analysis of five rare missense variants in F5 was also found to be associated with ACEI-AE or ARB-AE, P = 2.09 × 10 -3 . A combined gene risk score of these variants, and the common variants rs6025 and rs6020, showed that individuals carrying at least one variant had 2.21 (95% CI, 1.49-3.27, P = 6.30 × 10 -9 ) times the odds of having ACEI-AE or ARB-AE. The increased risk due to the common Leiden allele was confirmed in a genome-wide association study from the United States. A high risk of angioedema was also observed for the rs6020 variant that is the main coagulation defect-causing variant in black African and Asian populations. We found that deleterious missense variants in F5 are associated with an increased risk of ACEI-AE or ARB-AE.

OriginalsprogEngelsk
TidsskriftClinical Pharmacology and Therapeutics
Vol/bind108
Udgave nummer6
Sider (fra-til)1195-1202
Antal sider8
ISSN0009-9236
DOI
StatusUdgivet - dec. 2020

ID: 60285532